Eli Lilly and Company (NYSE: LLY) reported second quarter 2020 earnings results today. Revenues declined 2% year-over-year to $5.4 billion. Reported net income rose 6% to $1.4 billion and EPS grew 8% to $1.55. Adjusted EPS increased 26% to $1.89. For fiscal year 2020, the company expects reported EPS to be $6.48-6.68 and adjusted […]
Eli Lilly and Company (NYSE: LLY) reported second quarter 2020 earnings results today. Revenues declined 2% year-over-year to $5.4 billion. Reported net income rose 6% to $1.4 billion and EPS grew 8% to $1.55. Adjusted EPS increased 26% to $1.89. For fiscal year 2020, the company expects reported EPS to be $6.48-6.68 and adjusted […]
Eli Lilly and Company (NYSE: LLY) reported second quarter 2020 earnings results today.
Revenues declined 2% year-over-year to $5.4 billion.
Reported net income rose 6% to $1.4 billion and EPS grew 8% to $1.55. Adjusted EPS increased 26% to $1.89.
For fiscal year 2020, the company expects reported EPS to be $6.48-6.68 and adjusted EPS to be $7.20-7.40. Revenue is expected to come between $23.7 billion and $24.2 billion.
